glutathionylspermidine - patents, research & applications

41Patents

35Research papers

2Patents - last 3 years

0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#	Assignee	Patents
1	Nuevolution AS	10
2	Xrpro Sciences Inc	5
3	Defined Diagnostics LLC	2
4	University of California	2
5	University of California San Diego UCSD	2

6	University of Texas System	2
7	Icagen Inc	1
8	Icagen LLC	1
9	University of California Berkeley	1

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#	Code	Area	Patents
1	`C12N`	Microorganisms, enzymes	26
2	`G01N`	Investigating / analysing materials	15
3	`A61K`	Medicinal preparations	11
4	`A61P`	Therapeutic activity (drug indications)	11
5	`C40B`		9

6	`G21K`		8
7	`C12Q`	Measuring/testing involving enzymes	7
8	`Y10S`	Cross-reference (legacy)	7
9	`C12P`	Fermentation, enzyme processes	4
10	`A01N`	Preservation of bodies; biocides; pest repellents	2

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Most-cited patents

Patents ranked by forward citations reveal the foundational inventions the field continues to build on.

Title	Year	Assignee
Glutathionylspermidine synthetase	2001	LEOPOLD FLOHE
GLUTATHIONYLSPERMIDINE SYNTHETASE	2000	FLOHE LEOPOLD
Glutathionylspermidine synthetase	2000	LEOPOLD FLOHE
GLUTATHIONYLSPERMIDINE SYNTHETASE	1999	FLOHE, LEOPOLD, PROF. DR.
Glutathionylspermidine synthetase	1998	FLOHE, LEOPOLD

Where research is gaining momentum

Research themes ranked by publication activity show where scientific interest is accelerating around this compound.

#	Research topic	Papers
1	Exercise and Physiological Responses	1

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#	Author	Affiliation	Papers
1	Alan H. Fairlamb	Wellcome Trust	7
2	R. Luise Krauth‐Siegel	Heidelberg University	6
3	Chun‐Hung Lin	National Taiwan University	5
4	Christopher T. Walsh	Harvard University	4
5	Leopold Flohé	University of Padua	4

6	Marcelo A. Comini	Institut Pasteur de Montevideo	4
7	Bing‐Yu Chiang	Institute of Biological Chemistry, Academia Sinica	3
8	David S. Kwon	Harvard University	3
9	James K. Coward	University of Michigan	3
10	Mark R. Ariyanayagam	University of London	3

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Title	Year	Cited by	Topic
Substrate interactions between trypanothione reductase and N¹‐glutathionylspermidine disulphide at 0.28‐nm resolution	1993	111	Research on Leishmaniasis Studies
Valdiation of Trypanosoma brucei trypanothione synthetase as drug target	2004	108	Research on Leishmaniasis Studies
Glutathionylspermidine Metabolism in Escherichia coli.	1995	89	Polyamine Metabolism and Applications
Ecology of cold environments: new insights of bacterial metabolic adaptation through an integrated genomic-phenomic approach	2017	77	Genomics and Phylogenetic Studies
The Dithiol Glutaredoxins of African Trypanosomes Have Distinct Roles and Are Closely Linked to the Unique Trypanothione Metabolism	2010	75	Parasites and Host Interactions

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of glutathionylspermidine?

Glutathionylspermidine has the molecular formula C17H34N6O5S and a molecular weight of 434.556 g/mol.

Which organizations hold the most patents related to glutathionylspermidine?

Nuevolution AS holds the largest patent portfolio with 10 patents, followed by Xrpro Sciences Inc with 5 patents. Academic institutions including University of California, University of California San Diego, University of Texas System, and University of California Berkeley each hold 2 patents, while Icagen Inc and Icagen LLC each hold 1 patent.

What are the most productive research areas for glutathionylspermidine based on patent classification?

Patents covering glutathionylspermidine are most frequently classified under C12N (26 patents), followed by G01N (15 patents), A61K (11 patents), and A61P (11 patents). These classifications indicate focus on biotechnology, measurement techniques, and pharmaceutical preparations.

Which researchers have published the most on glutathionylspermidine?

Alan H. Fairlamb from Wellcome Trust leads with 7 papers, followed by R. Luise Krauth-Siegel from Heidelberg University with 6 papers. Chun-Hung Lin from National Taiwan University, Christopher T. Walsh from Harvard University, Leopold Flohé from University of Padua, and Marcelo A. Comini from Institut Pasteur de Montevideo each have 4 papers.

What is the current research activity level for glutathionylspermidine?

Recent activity is limited: only 2 patents were granted in the last 3 years (2022–2025), and no papers were published in that period. Historically, the aggregate contains 41 total patents and 35 papers, with significant work appearing in the 1990s and 2000s, particularly on trypanothione metabolism and parasitic diseases.